

GeneDx Holdings (NASDAQ:WGS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of GeneDx Holdings (NASDAQ:WGS) through any online brokerage.
Other companies in GeneDx Holdings’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
GeneDx Holdings has a consensus price target of $88.40.
The stock price for GeneDx Holdings (NASDAQ: WGS) is $60.4 last updated November 9, 2026 at 5:21 PM EST.
There are no upcoming dividends for GeneDx Holdings.
GeneDx Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for GeneDx Holdings.
GeneDx Holdings is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing...